Pfizer's new COVID vaccine shows promising results with 4x immunity boost, but Kennedy's restrictions leave most Americans ...

In August, the U.S. Food and Drug Administration approved the new COVID-19 booster shots, but with certain restrictions.

Drugmaker Pfizer Inc said on Tuesday it does not yet have data from the late-stage trial of the COVID-19 vaccine it is developing with Germany's BioNTech SE , and provided a timeline that makes its ...

SAN FRANCISCO -- One of the front-runners in the quest for a COVID-19 vaccine is reporting hopeful news. Pfizer says its vaccine is proving to be safe during phase three trials. RELATED: Oxford, ...

Senior sources in the British government expect that a verdict on whether Pfizer Inc-backed COVID-19 vaccine works will be available before the results are in on AstraZeneca Plc's competing vaccine, ...

Pfizer is backed by strong H1 results, a promising pipeline, improved financials, and solid valuation with long-term growth ...

The CHMP’s recommendation will be reviewed by the European Commission (EC), which is expected to make its final decision soon. Pfizer and BioNTech have already initiated manufacturing of the ...

The Food and Drug Administration will likely authorize Pfizer's COVID-19 booster shot for adolescents aged 12 to 15 by next week, The Washington Post and The New York Times reported on Thursday. The ...

In new data released by the Food and Drug Administration on Wednesday, Pfizer said vaccine booster shots would restore protection against COVID-19 to up to 95% in real-world settings, CNBC and ABC ...

The market for VZV infection treatment is driven by increased vaccination and antiviral use, rising elderly populations, and strong immunization programs in developed regions. Key opportunities ...

With a market cap of $139.4 billion, Pfizer Inc. (PFE) is a global biopharmaceutical company headquartered in New York, known ...